Article Information
History
- November 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alexandre Pellan Cheng1,2,+,#,
- Adam J. Widman1,3,+,
- Anushri Arora1,2,+,
- Itai Rusinek4,
- William F. Hooper1,
- Rebecca Murray1,2,
- Daniel Halmos1,2,
- Theophile Langanay1,2,
- Giorgio Inghirami2,
- Soren Germer1,
- Melissa Marton1,
- Dina Manaa1,
- Adrienne Helland1,
- Rob Furatero1,
- Jaime McClintock1,
- Lara Winterkorn1,
- Zoe Steinsnyder1,
- Yohyoh Wang1,2,
- Srinivas Rajagopalan1,2,
- Asrar I. Alimohamed5,
- Murtaza S. Malbari2,
- Ashish Saxena2,
- Margaret K. Callahan3,
- Dennie T. Frederick5,
- Lavinia Spain6,7,
- Ariel Jaimovich4,
- Doron Lipson4,
- Samra Turajlic6,7,
- Michael C. Zody1,
- Nasser K. Altorki2,
- Jedd D. Wolchok2,8,
- Michael A. Postow2,3,
- Nicolas Robine1,
- Genevieve Boland5 and
- Dan A. Landau1,2,#
- 1New York Genome Center, New York, NY, USA
- 2Weill Cornell Medicine, New York, NY, USA
- 3Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 4Ultima Genomics, Newark, CA, USA
- 5Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA
- 6Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
- 7Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
- 8Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- ↵#Correspondence: alcheng{at}nygenome.org and dal3005{at}med.cornell.edu
↵+ These authors contributed equally
Posted November 17, 2022.
Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring
